Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
NCT01568580
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Interventions
DRUG:
GreenGene
Sponsor
Green Cross Corporation